Xia, Congying
Rook, Mieneke
Pelgrim, Gert Jan
Sidorenkov, Grigory
Wisselink, Hendrik J.
van Bolhuis, Jurjen N.
van Ooijen, Peter M. A.
Guo, Jiapan
Oudkerk, Matthijs
Groen, Harry
van den Berge, Maarten
van der Harst, Pim
Dijkstra, Hildebrand
Vonder, Marleen
Heuvelmans, Marjolein A.
Dorrius, Monique D.
De Deyn, Peter Paul
de Bock, Geertruida H.
Dotinga, Aafje
Vliegenthart, Rozemarijn http://orcid.org/0000-0002-7262-3376
Funding for this research was provided by:
Siemens Healthineers
Article History
Received: 16 October 2018
Accepted: 10 April 2019
First Online: 23 April 2019
Compliance with ethical standards
:
: Rozemarijn Vliegenthart has received an institutional research grant from Siemens Healthineers. Matthijs Oudkerk is employed by iDNA B. V. Harry J. M. Groen is a board member of the NELSON screening trial and provides consultancy for BMS MERCK, PFIZER, TAKEDA, NOVARTIS. Other authors declare that they have no conflict of interest.